Dr Frank Mathias, currently CEO at Rentschler Biopharma, will join Oxford Biomedica as CEO and Board Director...
Up to date
Appointments
At the beginning of november, OxSonics Therapeutics has appointed Jérôme Marzinski as its Chief Executive...
Aurobac Therapeutics has appointed Florence Séjourné as CEO. The French company is a joint venture, founded...
Bioxodes SA,based in Marche-en-Famenne, Belgium, has appointed Marc Dechamps as its new CEO. Company founder,...
French MaaT Pharma has appointed Nathalie Corvaïa as Chief Scientific Officer and will strengthens its R&D...
Leiden-based Mimetas, specialist in organ-on-chip-based disease models for drug discovery and development,...
Share
